Changes in Plasma Amino Acid Appearance After Adding Bacillus Coagulans GBI-30, 6086 to Milk Protein Concentrate

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Protein Malabsorption
Interventions
DIETARY_SUPPLEMENT

Bacillus Coagulans GBI-30, 6086

In a randomized, double-blind, crossover fashion, study participants will supplement on a daily basis for two weeks during one study period with a 25-gram dose of either milk protein concentrate or a 25-gram dose of milk protein concentrate with bacillus coagulans GBI-30, 6086. Each dose will be ingested at the same time of day with 8 - 12 fluid ounces of cold tap water. All participants will be required to complete a supplementation log to document when each dose of their assigned protein is consumed. Upon completion of their first assigned study protocol period, participants will observe a three-week washout period by returning to their normal dietary intake and physical activity habits before beginning supplementation for the remaining study period.

Trial Locations (1)

63301

Lindenwood University, Saint Charles

All Listed Sponsors
collaborator

Increnovo, LLC

INDUSTRY

lead

Lindenwood University

OTHER

NCT05313178 - Changes in Plasma Amino Acid Appearance After Adding Bacillus Coagulans GBI-30, 6086 to Milk Protein Concentrate | Biotech Hunter | Biotech Hunter